APA (7th ed.) Citation

B, D., M, C., SC, C., R, S., J, G., S, C., . . . RE, C. (2026). Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial. PLoS medicine, 23(2), e1004758. https://doi.org/10.1371/journal.pmed.1004758

Chicago Style (17th ed.) Citation

B, Durovni, et al. "Acceptability and Safety of One Versus Three Months of Rifapentine and Isoniazid to Prevent Tuberculosis in People Exposed in the Household or Workplace in Brazil: The Ultra-Curto Randomized Controlled Trial." PLoS Medicine 23, no. 2 (2026): e1004758. https://doi.org/10.1371/journal.pmed.1004758.

MLA (9th ed.) Citation

B, Durovni, et al. "Acceptability and Safety of One Versus Three Months of Rifapentine and Isoniazid to Prevent Tuberculosis in People Exposed in the Household or Workplace in Brazil: The Ultra-Curto Randomized Controlled Trial." PLoS Medicine, vol. 23, no. 2, 2026, p. e1004758, https://doi.org/10.1371/journal.pmed.1004758.